These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7174033)

  • 1. Homing of macrophages in tumor immunity.
    Gupta N; Aikat BK; Sehgal S
    Indian J Med Res; 1982 Sep; 76():424-9. PubMed ID: 7174033
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo suppression of syngeneic murine fibrosarcoma by macrophages and lymphocytes.
    Gupta N; Aikat BK; Sehgal S
    Indian J Med Res; 1982 Apr; 75():583-9. PubMed ID: 7106899
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased prostaglandin synthesis by macrophages from tumor-bearing mice.
    Pelus LM; Bockman RS
    J Immunol; 1979 Nov; 123(5):2118-25. PubMed ID: 489975
    [No Abstract]   [Full Text] [Related]  

  • 4. Adherent cells (macrophages?) in tumor-bearing mice suppress MLC responses.
    Garrigues HJ; Romero P; Hellström I; Hellström KE
    Cell Immunol; 1981 May; 60(1):109-18. PubMed ID: 6453654
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
    Vaage J; Jones RD; Brown BW
    Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
    [No Abstract]   [Full Text] [Related]  

  • 6. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.
    Vaage J
    Cancer Res; 1971 Nov; 31(11):1655-62. PubMed ID: 5121668
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity.
    Bonventre PF; Nickol AD; Ball EJ; Michael JG; Bubel HC
    J Reticuloendothel Soc; 1982 Jul; 32(1):25-35. PubMed ID: 6290658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of tumour inhibition by activated macrophages in vitro.
    Orinda DA
    East Afr Med J; 1978 Apr; 55(4):177-81. PubMed ID: 679868
    [No Abstract]   [Full Text] [Related]  

  • 9. Concomitant immunity and specific desensitization in murine tumor hosts.
    Vaage J
    Isr J Med Sci; 1973 Mar; 9(3):332-43. PubMed ID: 4710041
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on the effect of a transplanted methylcholanthrene-induced fibrosarcoma on humoral immunity in CBA mice.
    James K; Milne I; Warr G
    Clin Exp Immunol; 1974 Oct; 18(2):243-50. PubMed ID: 4468197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced changes in established tumor immunity.
    Vaage J; Doroshow JH; DuBois TT
    Cancer Res; 1974 Jan; 34(1):129-37. PubMed ID: 4809453
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific triggering of macrophage accumulation at the site of secondary tumor challenge in mice with concomitant tumor immunity.
    Hopper KE; Nelson DS
    Cell Immunol; 1979 Sep; 47(1):163-9. PubMed ID: 509531
    [No Abstract]   [Full Text] [Related]  

  • 13. Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells.
    Sodhi A; Tandon P; Sarna S
    Arch Geschwulstforsch; 1985; 55(1):47-61. PubMed ID: 3872651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
    Weissman IL
    J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
    [No Abstract]   [Full Text] [Related]  

  • 15. Lectin potentiation of BCG-contact-mediated antitumor action.
    Poduval TB; Seshadri M; Sundaram K
    J Natl Cancer Inst; 1980 Nov; 65(5):909-12. PubMed ID: 6933260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
    Vaage J
    Cancer Res; 1973 Mar; 33(3):493-503. PubMed ID: 4689898
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of C. parvum therapy on intratumoral macrophage subpopulations.
    McBride WH; Moore K
    Adv Exp Med Biol; 1982; 155():731-6. PubMed ID: 7158508
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemokinetic response of activated macrophages to soluble products of neoplastic cells.
    Snodgrass MJ; Harris TM; Kaplan AM
    Cancer Res; 1978 Sep; 38(9):2925-9. PubMed ID: 679201
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.
    Nelson M; Nelson DS
    Immunology; 1978 Feb; 34(2):277-90. PubMed ID: 627408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of vitamin E against immunosuppression induced by adriamycin, mitomycin C and 5-fluorouracil in mice.
    Yasunaga T; Ohgaki K; Inamoto T; Kan N; Hikasa Y
    Nihon Geka Hokan; 1983 Sep; 52(5):591-601. PubMed ID: 6426418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.